{"transactions":[{"id":1760067,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":5774,"kind":"organization","name":"AGENUS INC","symbol":"AGEN","position":1,"cik":"0001098972","reported_name":"AGENUS INC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-10-16T21:49:39.000Z","date":"2023-10-16","kind":"purchase","planned":false,"acquired":true,"shares":429,"price":1.0992,"value":471.5568,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Agenus Inc. undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market purchases reported on this line occurred at a weighted average price of $1.0992 (range of $1.09 to $1.10)."}],"balance_after":21772863,"source":{"system":"sec-edgar","filing":"0000950170-23-053601","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1098972/000095017023053601/ownership.xml","form_type":"4"}},{"id":1760066,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":5774,"kind":"organization","name":"AGENUS INC","symbol":"AGEN","position":1,"cik":"0001098972","reported_name":"AGENUS INC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-10-16T21:49:39.000Z","date":"2023-10-13","kind":"purchase","planned":false,"acquired":true,"shares":19373,"price":1.1,"value":21310.3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Agenus Inc. undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market purchases reported on this line occurred at a price of $1.10."}],"balance_after":21772434,"source":{"system":"sec-edgar","filing":"0000950170-23-053601","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1098972/000095017023053601/ownership.xml","form_type":"4"}},{"id":1760065,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":5774,"kind":"organization","name":"AGENUS INC","symbol":"AGEN","position":1,"cik":"0001098972","reported_name":"AGENUS INC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-10-16T21:49:39.000Z","date":"2023-10-12","kind":"purchase","planned":false,"acquired":true,"shares":3173,"price":1.0994,"value":3488.3962,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Open market purchases reported on this line occurred at a weighted average price of $1.0994 (range of $1.08 to $1.10)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Agenus Inc. undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price."}],"balance_after":21753061,"source":{"system":"sec-edgar","filing":"0000950170-23-053601","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1098972/000095017023053601/ownership.xml","form_type":"4"}},{"id":1763907,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":5774,"kind":"organization","name":"AGENUS INC","symbol":"AGEN","position":1,"cik":"0001098972","reported_name":"AGENUS INC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-10-06T20:26:25.000Z","date":"2023-10-04","kind":"purchase","planned":false,"acquired":true,"shares":15001,"price":1.0919,"value":16379.5919,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Open market purchases reported on this line occurred at a weighted average price of $1.0919 (range of $1.02 to $1.10)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Agenus Inc. undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price."}],"balance_after":21749888,"source":{"system":"sec-edgar","filing":"0000950170-23-052408","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1098972/000095017023052408/ownership.xml","form_type":"4"}},{"id":1792207,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":5774,"kind":"organization","name":"AGENUS INC","symbol":"AGEN","position":1,"cik":"0001098972","reported_name":"AGENUS INC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-08-31T21:53:25.000Z","date":"2023-08-29","kind":"purchase","planned":false,"acquired":true,"shares":29678,"price":1.5168,"value":45015.5904,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Open market purchases reported on this line occurred at a weighted average price of $1.5168 (range of $1.50 to $1.52)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Agenus Inc. undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price."}],"balance_after":21734887,"source":{"system":"sec-edgar","filing":"0000950170-23-045816","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1098972/000095017023045816/ownership.xml","form_type":"4"}},{"id":1795550,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":5774,"kind":"organization","name":"AGENUS INC","symbol":"AGEN","position":1,"cik":"0001098972","reported_name":"AGENUS INC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-08-28T21:15:39.000Z","date":"2023-08-28","kind":"purchase","planned":false,"acquired":true,"shares":12808,"price":1.4499,"value":18570.3192,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Agenus Inc. undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market purchases reported on this line occurred at a weighted average price of $1.4499 (range of $1.44 to $1.45)."}],"balance_after":21705209,"source":{"system":"sec-edgar","filing":"0000899243-23-018546","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1098972/000089924323018546/doc4.xml","form_type":"4"}},{"id":1795549,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":5774,"kind":"organization","name":"AGENUS INC","symbol":"AGEN","position":1,"cik":"0001098972","reported_name":"AGENUS INC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-08-28T21:15:39.000Z","date":"2023-08-24","kind":"purchase","planned":false,"acquired":true,"shares":170244,"price":1.5443,"value":262907.8092,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Open market purchases reported on this line occurred at a weighted average price of $1.5443 (range of $1.52 to $1.55)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Agenus Inc. undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price."}],"balance_after":21692401,"source":{"system":"sec-edgar","filing":"0000899243-23-018546","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1098972/000089924323018546/doc4.xml","form_type":"4"}},{"id":1877053,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":5774,"kind":"organization","name":"AGENUS INC","symbol":"AGEN","position":1,"cik":"0001098972","reported_name":"AGENUS INC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-26T21:12:08.000Z","date":"2023-05-01","kind":"other","planned":false,"acquired":false,"shares":5006397,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 1, 2023, Agenus Inc. (\"Agenus\") paid its previously announced pro rata stock dividend (the \"Dividend\") consisting of an aggregate of 5,006,397 shares of common stock of MiNK Therapeutics, Inc. (\"MiNK\") held by Agenus (the \"Dividend Shares\") to record holders of Agenus's common stock as of April 17, 2023 (the \"Record Date\").  Agenus distributed 0.0146 of a share of MiNK's common stock for each share of Agenus's common stock outstanding as of the close of business on the Record Date. No fractional shares were issued in connection with the Dividend and the equityholders of Agenus who were entitled to receive fractional shares of the Dividend Stock received cash (without interest) in lieu of such fractional shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Form 4 filed by Agenus on May 3, 2023 inadvertently underreported the number of Dividend Shares distributed to record holders of Agenus's common stock as of the Record Date by 18,316 shares."}],"balance_after":21326369,"source":{"system":"sec-edgar","filing":"0000950170-23-024556","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1098972/000095017023024556/ownership.xml","form_type":"4/A","original_submission_date":"2023-05-03"}},{"id":1895587,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":5774,"kind":"organization","name":"AGENUS INC","symbol":"AGEN","position":1,"cik":"0001098972","reported_name":"AGENUS INC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-12T21:18:23.000Z","date":"2023-05-11","kind":"purchase","planned":false,"acquired":true,"shares":23361,"price":1.4275,"value":33347.8275,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Agenus Inc. undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market purchases reported on this line occurred at a weighted average price of $1.4275 (range of $1.38 to $1.495)."}],"balance_after":21640473,"source":{"system":"sec-edgar","filing":"0000950170-23-021854","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1098972/000095017023021854/ownership.xml","form_type":"4"}},{"id":1895586,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":5774,"kind":"organization","name":"AGENUS INC","symbol":"AGEN","position":1,"cik":"0001098972","reported_name":"AGENUS INC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-12T21:18:23.000Z","date":"2023-05-10","kind":"purchase","planned":false,"acquired":true,"shares":22065,"price":1.509,"value":33296.085,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Open market purchases reported on this line occurred at a weighted average price of $1.509 (range of $1.47 to $1.54)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Agenus Inc. undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price."}],"balance_after":21617112,"source":{"system":"sec-edgar","filing":"0000950170-23-021854","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1098972/000095017023021854/ownership.xml","form_type":"4"}},{"id":1903310,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":5774,"kind":"organization","name":"AGENUS INC","symbol":"AGEN","position":1,"cik":"0001098972","reported_name":"AGENUS INC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-05T22:00:56.000Z","date":"2023-05-05","kind":"purchase","planned":false,"acquired":true,"shares":200,"price":1.25,"value":250.0,"ownership":{"direct":true},"balance_after":21595047,"source":{"system":"sec-edgar","filing":"0000950170-23-018401","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1098972/000095017023018401/ownership.xml","form_type":"4"}},{"id":1903309,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":5774,"kind":"organization","name":"AGENUS INC","symbol":"AGEN","position":1,"cik":"0001098972","reported_name":"AGENUS INC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-05T22:00:56.000Z","date":"2023-05-05","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":0.9485,"value":94850.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"On May 5, 2023, Agenus purchased 100,000 shares of MiNk Therapeutics, Inc. common stock from Garo Armen, Agenus's Chairman and CEO, at the same  price he paid to acquire the shares on May 2, 2023.  The acquisition price represents a 40% discount to the market price as of today's market close."}],"balance_after":21594847,"source":{"system":"sec-edgar","filing":"0000950170-23-018401","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1098972/000095017023018401/ownership.xml","form_type":"4"}},{"id":1903308,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":5774,"kind":"organization","name":"AGENUS INC","symbol":"AGEN","position":1,"cik":"0001098972","reported_name":"AGENUS INC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-05T22:00:56.000Z","date":"2023-05-04","kind":"purchase","planned":false,"acquired":true,"shares":21473,"price":1.2223,"value":26246.4479,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Agenus Inc. undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market purchases reported on this line occurred at a weighted average price of $1.0789 (range of $1.20 to $1.25)."}],"balance_after":21494847,"source":{"system":"sec-edgar","filing":"0000950170-23-018401","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1098972/000095017023018401/ownership.xml","form_type":"4"}},{"id":1903307,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":5774,"kind":"organization","name":"AGENUS INC","symbol":"AGEN","position":1,"cik":"0001098972","reported_name":"AGENUS INC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-05T22:00:56.000Z","date":"2023-05-03","kind":"purchase","planned":false,"acquired":true,"shares":128689,"price":1.0789,"value":138842.5621,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Open market purchases reported on this line occurred at a weighted average price of $1.0789 (range of $0.9144 to $1.20)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Agenus Inc. undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price."}],"balance_after":21473374,"source":{"system":"sec-edgar","filing":"0000950170-23-018401","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1098972/000095017023018401/ownership.xml","form_type":"4"}},{"id":1906828,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":5774,"kind":"organization","name":"AGENUS INC","symbol":"AGEN","position":1,"cik":"0001098972","reported_name":"AGENUS INC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-03T21:39:44.000Z","date":"2023-05-01","kind":"other","planned":false,"acquired":false,"shares":4988273,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 1, 2023, Agenus Inc. (\"Agenus\") paid its previously announced pro rata stock dividend (the \"Dividend\") consisting of an aggregate of 4,988,081 shares of common stock of MiNK Therapeutics, Inc. (\"MiNK\") held by Agenus (the \"Dividend Shares\") to record holders of Agenus's common stock as of April 17, 2023 (the \"Record Date\"). Agenus distributed 0.0146 of a share of MiNK's common stock for each share of Agenus's common stock outstanding as of the close of business on the Record Date. No fractional shares were issued in connection with the Dividend and the equityholders of Agenus who were entitled to receive fractional shares of the Dividend Shares received cash (without interest) in lieu of such fractional shares and 192 MiNK shares owned by Agenus that represented the aggregate number of fractional shares that would have been distributed were retired."}],"balance_after":21344685,"source":{"system":"sec-edgar","filing":"0000899243-23-012119","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1098972/000089924323012119/doc4.xml","form_type":"4"}},{"id":2538429,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":5774,"kind":"organization","name":"AGENUS INC","symbol":"AGEN","position":1,"cik":"0001098972","reported_name":"AGENUS INC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Promissory Note","published_at":"2021-10-20T23:37:42.000Z","date":"2021-10-19","kind":"exercise","acquired":false,"shares":5451958,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The shares were received upon the automatic conversion of a convertible promissory note issued to Agenus Inc. by the issuer upon completion of the Issuer's initial public offering. The conversion rate of the note was equal to the quotient obtained by dividing (i) the amount due on the date of conversion by (ii) 80% of the per share price of the common stock sold in the initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were received upon the automatic conversion of a convertible promissory note issued to Agenus Inc. by the issuer upon completion of the Issuer's initial public offering. The conversion rate of the note was equal to the quotient obtained by dividing (i) the amount due on the date of conversion by (ii) 80% of the per share price of the common stock sold in the initial public offering."}],"balance_after":0,"derivative":{"exercise_date":"2021-10-19","expiration_date":"2022-07-01","underlying":"Common Stock","underlying_shares":5451958},"source":{"system":"sec-edgar","filing":"0000899243-21-040873","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1098972/000089924321040873/doc4.xml","form_type":"4"}},{"id":2538428,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":5774,"kind":"organization","name":"AGENUS INC","symbol":"AGEN","position":1,"cik":"0001098972","reported_name":"AGENUS INC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-20T23:37:42.000Z","date":"2021-10-19","kind":"exercise","acquired":false,"shares":5451958,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were received upon the automatic conversion of a convertible promissory note issued to Agenus Inc. by the issuer upon completion of the Issuer's initial public offering. The conversion rate of the note was equal to the quotient obtained by dividing (i) the amount due on the date of conversion by (ii) 80% of the per share price of the common stock sold in the initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were received upon the automatic conversion of a convertible promissory note issued to Agenus Inc. by the issuer upon completion of the Issuer's initial public offering. The conversion rate of the note was equal to the quotient obtained by dividing (i) the amount due on the date of conversion by (ii) 80% of the per share price of the common stock sold in the initial public offering."}],"balance_after":26332958,"source":{"system":"sec-edgar","filing":"0000899243-21-040873","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1098972/000089924321040873/doc4.xml","form_type":"4"}},{"id":2538427,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":5774,"kind":"organization","name":"AGENUS INC","symbol":"AGEN","position":1,"cik":"0001098972","reported_name":"AGENUS INC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-20T23:37:42.000Z","date":"2021-10-19","kind":"purchase","acquired":true,"shares":1400000,"price":12,"value":16800000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were purchased in this Issuer's initial public offering."}],"balance_after":20881000,"source":{"system":"sec-edgar","filing":"0000899243-21-040873","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1098972/000089924321040873/doc4.xml","form_type":"4"}}]}